Revolution Medicines, Inc.RVMD
Price (close)
$199.86
Market cap
$42.8B
P/E
—
Revenue (TTM)
$0
Net income
-$1.8B
Dividend yield
—
1-year total return
370.1%
Net margin
—
Revenue growth
—
Debt / equity
—
What Revolution Medicines, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $43.0M | $29.4M | $35.4M | $11.6M | $0 | $0 |
| Net income | -$108.2M | -$187.1M | -$248.7M | -$436.4M | -$600.1M | -$1.1B |
| Free cash flow | -$103.0M | -$153.7M | -$235.2M | -$358.3M | -$567.7M | -$913.7M |
More on RVMD.
- Revolution Medicines, Inc. summary
- Revolution Medicines, Inc. financial statements
- Revolution Medicines, Inc. key metrics
- Revolution Medicines, Inc. health scores and style box
- Revolution Medicines, Inc. earnings
- Revolution Medicines, Inc. dividends
- Revolution Medicines, Inc. valuation
- Revolution Medicines, Inc. ownership and insiders
- Revolution Medicines, Inc. peers
Figures from Revolution Medicines, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.